Form 4: CHEMED CEO McNamara Receives Stock Option Grant

CHEMED Corp. President and CEO Kevin J. McNamara was granted 58,672 stock options at an exercise price of $443.79, vesting over three years.

Summary

• Kevin J. McNamara, President and CEO of CHEMED Corp., was granted 58,672 stock options.
• The options have an exercise price of $443.79 per share.
• The transaction date for the grant was October 21, 2025.
• The options will vest in three equal annual installments, commencing on October 21, 2026.
• The expiration date for these options is October 21, 2030.
• Following this transaction, Mr. McNamara beneficially owns 266,159 derivative securities.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: Slightly positive as it indicates executive alignment with shareholder interests through long-term equity incentives, but it's a routine compensation disclosure.

Positives

• The grant of stock options aligns executive interests with shareholder value creation.
• The use of a Rule 10b5-1 plan indicates a pre-arranged, transparent transaction.

Future Outlook

The stock options will vest in three equal annual installments starting October 21, 2026, and expire on October 21, 2030, providing a long-term incentive for the CEO.

Industry Context

Executive stock option grants are a common form of long-term incentive compensation in publicly traded companies, particularly in the healthcare services sector where CHEMED operates, aiming to align management's financial interests with shareholder returns.

Comparison to Industry Standards

• Executive compensation structures, including stock option grants, vary widely across industries and company sizes. While the specific grant size and exercise price are unique to CHEMED and Mr. McNamara, the use of stock options with a multi-year vesting schedule is a standard practice for incentivizing long-term performance, comparable to practices at companies like Encompass Health Corporation (EHC) or LHC Group (LHCG) in the post-acute care space, which also utilize equity-based compensation for their executives.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for increased alignment between executive performance and shareholder value due to equity incentives.
• Management: Provides long-term incentive and potential for significant personal wealth creation tied to company stock performance.

Next Steps

• Vesting of 58,672 stock options in three equal annual installments commencing October 21, 2026.
• Potential exercise of options by Kevin J. McNamara before the October 21, 2030 expiration date.

Key Dates

Keywords

CHEMED, CHE, Kevin J. McNamara, Stock Options, Executive Compensation, Insider Transaction, Form 4, Rule 10b5-1, Equity Grant